Full Professor(heuristic)

Prostate Cancer Treatment and Research · Pulmonary and Respiratory Medicine

Compare more Pulmonary and Respiratory Medicine professors.

h-index62
i10-index177
Publications630
Citations25,572

Grants

7 total · 1 active

NIH #I01CX002189

High-dose Testosterone in Men with Metastatic Castration-resistant Prostate Cancer and ATM or CDK12 deficiency

Expiring Soon
Amount
—
Period
2021-10-01 → 2026-09-30
PIs
1

Awarded at VA PUGET SOUND HEALTHCARE SYSTEM

NIH #I01CX001963

Multicenter phase II study of first-line carboplatin followed by docetaxel versus first-line docetaxel followed by carboplatin for treatment of castration resistant prostate cancer

Amount
—
Period
2020-01-01 → 2024-12-31
PIs
1

Awarded at VA PUGET SOUND HEALTHCARE SYSTEM

NIH #R01CA082661

PHASE I TRIAL OF A PEPTIDE VACCINE AGAINST EGFRVIII

Amount
$200K–$300K
Period
1999-08-13 → 2006-12-31
PIs
1

Awarded at UNIVERSITY OF WASHINGTON

Active grants are a starting point, not proof of an opening. Confirm recruiting and funding with the professor, current students, and your written offer. Learn how to verify PhD funding →

All Grants

7 total · 1 active

NIH #I01CX002189

High-dose Testosterone in Men with Metastatic Castration-resistant Prostate Cancer and ATM or CDK12 deficiency

Expiring Soon
Amount
—
Period
2021-10-01 → 2026-09-30
PIs
1

Awarded at VA PUGET SOUND HEALTHCARE SYSTEM

NIH #I01CX001963

Multicenter phase II study of first-line carboplatin followed by docetaxel versus first-line docetaxel followed by carboplatin for treatment of castration resistant prostate cancer

Amount
—
Period
2020-01-01 → 2024-12-31
PIs
1

Awarded at VA PUGET SOUND HEALTHCARE SYSTEM

NIH #R01CA082661

PHASE I TRIAL OF A PEPTIDE VACCINE AGAINST EGFRVIII

Amount
$200K–$300K
Period
1999-08-13 → 2006-12-31
PIs
1

Awarded at UNIVERSITY OF WASHINGTON

NIH #M01RR000037

A PHASE I STUDY OF AN EGFRVIII PEPTIDE BASE VACCINE IN PATIENTS WITH CANCER

Amount
<$100K
Period
2005-08-01 → 2006-03-31
PIs
1

Awarded at UNIVERSITY OF WASHINGTON

NSF #0216015

Interagency Agreement: Scientists, Engineers and Technician

Amount
$100K–$200K
Period
2001-10-01 → 2002-09-30
PIs
1

Awarded at Department of Labor Bureau of Labor Statistics

NIH #K08CA060782

MODULATION OF RAS MEDIATED SIGNAL TRANSDUCTION

Amount
<$100K
Period
1993-09-07 → 1999-04-30
PIs
1

Awarded at UNIVERSITY OF WASHINGTON

NSF #9809359

Scientists, Engineers, and Technicians in Industry

Amount
$400K–$500K
Period
1998-02-01 → 1998-09-30
PIs
1

Awarded at Department of Labor Bureau of Labor Statistics

Recent Public Signals

  1. New paper: Supplementary Table S5 from Nucleosome Patterns in Circulating Tumor DNA Reveal Transcriptional Regulation of Advanced Prostate Cancer Phenotypes2025-12-11
  2. New preprint: CHIMERA-DDR: A Machine Learning Framework for Classifying Heterogeneous Mismatch-Repair and Homologous-Recombination Deficiency Patterns in Prostate Cancer2025-10-14
  3. New NIH award: High-dose Testosterone in Men with Metastatic Castration-resistant Prostate Cancer and ATM or CDK12 deficiency2021-10-01

Are you this professor?

No account needed — verify once with your ORCID iD to set recruiting status and correct your rank.

Data Freshness

  • Publications as of 2026-07-09
  • Grants as of 2026-08-26

Data may not be current

Find elsewhere

Institution / lab homepage Search on ResearchGate

ORCID: 0000-0003-4459-0295

Professor Insights

Career Trajectory